强直性脊柱炎|NSAIDs在强直性脊柱炎治疗中的应用( 二 )


11.van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991.
12.Tam LS, Wei JC, Aggarwal A, et al. 2018 APLAR axial spondyloarthritis treatment recommendations. Int J Rheum Dis. 2019;22(3):340-356.
13.Benhamou M, Gossec L, Dougados M. Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. Rheumatology (Oxford). 2010;49(3):536-541.
14.Wanders A, van der Heijde D, Landewé R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 2005;52:1756-65.
15.Fan, M., Liu, J., Zhao, B., et al. Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta?analysis of randomized, double?blinded, controlled trials. 2020;19(4):3031-3041.
16.Sieper J, Klopsch T, Richter M, et alComparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled studyAnnals of the Rheumatic Diseases 2008;67:323-329.

推荐阅读